Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-023235
Filing Date
2024-09-11
Accepted
2024-09-11 17:36:37
Documents
2
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 form3-09112024_090933.html 3  
1 form3-09112024_090933.xml 3 12428
2 ex24-09112024_090933.htm EX-24 5791
  Complete submission text file 0001415889-24-023235.txt   19660
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OVID THERAPEUTICS INC. 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address
ALEXANDER MARGARET A. (Reporting) CIK: 0002036798 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38085 | Film No.: 241293376